Viewing Study NCT01292512



Ignite Creation Date: 2024-05-05 @ 11:17 PM
Last Modification Date: 2024-10-26 @ 10:31 AM
Study NCT ID: NCT01292512
Status: COMPLETED
Last Update Posted: 2020-03-27
First Post: 2011-02-08

Brief Title: Bereavement Management - Description Assessment and Care
Sponsor: University of Aarhus
Organization: University of Aarhus

Study Overview

Official Title: Bereavement Management Description Assessment and Care A Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2012-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to develop a risk assessment tool to identify bereaved in risk of complicated grief reactions and to implement a bereavement management programme in primary health care based on the Dual Process Model of coping with bereavement Furthermore to enhance bereavement care in general practice and to enhance patients self-management in bereavement care
Detailed Description: In Denmark alone there are approximately 55000 deaths annually which leave approximately 200000 bereaved close relatives International studies show that 10-15 of bereaved persons develop complications following the death of a close relative If those studies hold true approximately 20 - 30000 individuals annually will develop complications as a result of suffering a loss and there is hardly any knowledge of how bereavement is treated or even legitimized in primary care and referred on to specialized psychological or psychiatric care The field of bereavement is in need of studies that validate the theoretical underpinnings of the research area enhanced assessment of predictive risk factors and updated intervention methods in short a scientifically valid management programme

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None